Cargando…
Analysing population-based cancer survival – settling the controversies
BACKGROUND: The relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis. METHODS: We carefully define and explain the differences between the various measures of survival (overall survival, cr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135814/ https://www.ncbi.nlm.nih.gov/pubmed/27912732 http://dx.doi.org/10.1186/s12885-016-2967-9 |
_version_ | 1782471613946527744 |
---|---|
author | Pohar Perme, Maja Estève, Jacques Rachet, Bernard |
author_facet | Pohar Perme, Maja Estève, Jacques Rachet, Bernard |
author_sort | Pohar Perme, Maja |
collection | PubMed |
description | BACKGROUND: The relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis. METHODS: We carefully define and explain the differences between the various measures of survival (overall survival, crude mortality, net survival and relative survival ratio) and study their differences using colon and prostate cancer data extracted from the national population-based cancer registry of Slovenia as well as simulated data. RESULTS: The colon and prostate cancer data demonstrate clearly that when analysing population-based data, it is useful to split the overall mortality in crude probabilities of dying from cancer and from other causes. Complemented by net survival, it provides a complete picture of cancer survival in a given population. But when comparisons of different populations as defined for example by place or time are of interest, our simulated data demonstrate that net survival is the only measure to be used. CONCLUSIONS: The choice of the method should be done in two steps: first, one should determine the measure of interest and second, one should choose among the methods that estimate that measure consistently. |
format | Online Article Text |
id | pubmed-5135814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51358142016-12-15 Analysing population-based cancer survival – settling the controversies Pohar Perme, Maja Estève, Jacques Rachet, Bernard BMC Cancer Research Article BACKGROUND: The relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis. METHODS: We carefully define and explain the differences between the various measures of survival (overall survival, crude mortality, net survival and relative survival ratio) and study their differences using colon and prostate cancer data extracted from the national population-based cancer registry of Slovenia as well as simulated data. RESULTS: The colon and prostate cancer data demonstrate clearly that when analysing population-based data, it is useful to split the overall mortality in crude probabilities of dying from cancer and from other causes. Complemented by net survival, it provides a complete picture of cancer survival in a given population. But when comparisons of different populations as defined for example by place or time are of interest, our simulated data demonstrate that net survival is the only measure to be used. CONCLUSIONS: The choice of the method should be done in two steps: first, one should determine the measure of interest and second, one should choose among the methods that estimate that measure consistently. BioMed Central 2016-12-03 /pmc/articles/PMC5135814/ /pubmed/27912732 http://dx.doi.org/10.1186/s12885-016-2967-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Pohar Perme, Maja Estève, Jacques Rachet, Bernard Analysing population-based cancer survival – settling the controversies |
title | Analysing population-based cancer survival – settling the controversies |
title_full | Analysing population-based cancer survival – settling the controversies |
title_fullStr | Analysing population-based cancer survival – settling the controversies |
title_full_unstemmed | Analysing population-based cancer survival – settling the controversies |
title_short | Analysing population-based cancer survival – settling the controversies |
title_sort | analysing population-based cancer survival – settling the controversies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135814/ https://www.ncbi.nlm.nih.gov/pubmed/27912732 http://dx.doi.org/10.1186/s12885-016-2967-9 |
work_keys_str_mv | AT poharpermemaja analysingpopulationbasedcancersurvivalsettlingthecontroversies AT estevejacques analysingpopulationbasedcancersurvivalsettlingthecontroversies AT rachetbernard analysingpopulationbasedcancersurvivalsettlingthecontroversies |